Pan, Yuan http://orcid.org/0000-0002-9465-8289
Hysinger, Jared D.
Yalçın, Belgin http://orcid.org/0000-0001-9689-9062
Lennon, James J.
Byun, Youkyeong Gloria
Raghavan, Preethi
Schindler, Nicole F.
Anastasaki, Corina
Chatterjee, Jit
Ni, Lijun
Xu, Haojun
Malacon, Karen
Jahan, Samin M.
Ivec, Alexis E.
Aghoghovwia, Benjamin E. http://orcid.org/0000-0001-5630-1361
Mount, Christopher W.
Nagaraja, Surya
Scheaffer, Suzanne
Attardi, Laura D.
Gutmann, David H. http://orcid.org/0000-0002-3127-5045
Monje, Michelle http://orcid.org/0000-0002-3547-237X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA258384)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (DP1NS111132)
Gatsby Charitable Foundation
U.S. Department of Defense (W81XWH-15-1-0131)
Cancer Prevention and Research Institute of Texas (RR210085)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R35NS07211)
Article History
Received: 22 September 2022
Accepted: 18 April 2024
First Online: 30 May 2024
Competing interests
: M.M. or her family holds equity in MapLight Therapeutics and CARGO Therapeutics. The other authors declare no competing interests.